Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Medicine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Medicine Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Medicine Market Perspective (2018-2034)
2.2 RNA Medicine Growth Trends by Region
2.2.1 Global RNA Medicine Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 RNA Medicine Historic Market Size by Region (2018-2023)
2.2.3 RNA Medicine Forecasted Market Size by Region (2024-2034)
2.3 RNA Medicine Market Dynamics
2.3.1 RNA Medicine Industry Trends
2.3.2 RNA Medicine Market Drivers
2.3.3 RNA Medicine Market Challenges
2.3.4 RNA Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Medicine Players by Revenue
3.1.1 Global Top RNA Medicine Players by Revenue (2018-2023)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2018-2023)
3.2 Global RNA Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Medicine Revenue
3.4 Global RNA Medicine Market Concentration Ratio
3.4.1 Global RNA Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Medicine Revenue in 2024
3.5 RNA Medicine Key Players Head office and Area Served
3.6 Key Players RNA Medicine Product Solution and Service
3.7 Date of Enter into RNA Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Medicine Breakdown Data by Type
4.1 Global RNA Medicine Historic Market Size by Type (2018-2023)
4.2 Global RNA Medicine Forecasted Market Size by Type (2024-2034)
5 RNA Medicine Breakdown Data by Application
5.1 Global RNA Medicine Historic Market Size by Application (2018-2023)
5.2 Global RNA Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America RNA Medicine Market Size (2018-2034)
6.2 North America RNA Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America RNA Medicine Market Size by Country (2018-2023)
6.4 North America RNA Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Medicine Market Size (2018-2034)
7.2 Europe RNA Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe RNA Medicine Market Size by Country (2018-2023)
7.4 Europe RNA Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Medicine Market Size (2018-2034)
8.2 Asia-Pacific RNA Medicine Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific RNA Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Medicine Market Size (2018-2034)
9.2 Latin America RNA Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America RNA Medicine Market Size by Country (2018-2023)
9.4 Latin America RNA Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Medicine Market Size (2018-2034)
10.2 Middle East & Africa RNA Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa RNA Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer RNA Medicine Introduction
11.1.4 Pfizer Revenue in RNA Medicine Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche RNA Medicine Introduction
11.2.4 Roche Revenue in RNA Medicine Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Detail
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis RNA Medicine Introduction
11.3.4 Sanofi-Aventis Revenue in RNA Medicine Business (2018-2023)
11.3.5 Sanofi-Aventis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories RNA Medicine Introduction
11.4.4 Abbott Laboratories Revenue in RNA Medicine Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Detail
11.5.2 Arrowhead Pharmaceuticals Business Overview
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Introduction
11.5.4 Arrowhead Pharmaceuticals Revenue in RNA Medicine Business (2018-2023)
11.5.5 Arrowhead Pharmaceuticals Recent Development
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Detail
11.6.2 Benitec Biopharma Business Overview
11.6.3 Benitec Biopharma RNA Medicine Introduction
11.6.4 Benitec Biopharma Revenue in RNA Medicine Business (2018-2023)
11.6.5 Benitec Biopharma Recent Development
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Detail
11.7.2 Calimmune Inc Business Overview
11.7.3 Calimmune Inc RNA Medicine Introduction
11.7.4 Calimmune Inc Revenue in RNA Medicine Business (2018-2023)
11.7.5 Calimmune Inc Recent Development
11.8 Dicerna
11.8.1 Dicerna Company Detail
11.8.2 Dicerna Business Overview
11.8.3 Dicerna RNA Medicine Introduction
11.8.4 Dicerna Revenue in RNA Medicine Business (2018-2023)
11.8.5 Dicerna Recent Development
11.9 Gradalis
11.9.1 Gradalis Company Detail
11.9.2 Gradalis Business Overview
11.9.3 Gradalis RNA Medicine Introduction
11.9.4 Gradalis Revenue in RNA Medicine Business (2018-2023)
11.9.5 Gradalis Recent Development
11.10 Quark
11.10.1 Quark Company Detail
11.10.2 Quark Business Overview
11.10.3 Quark RNA Medicine Introduction
11.10.4 Quark Revenue in RNA Medicine Business (2018-2023)
11.10.5 Quark Recent Development
11.11 RXi
11.11.1 RXi Company Detail
11.11.2 RXi Business Overview
11.11.3 RXi RNA Medicine Introduction
11.11.4 RXi Revenue in RNA Medicine Business (2018-2023)
11.11.5 RXi Recent Development
11.12 Senesco
11.12.1 Senesco Company Detail
11.12.2 Senesco Business Overview
11.12.3 Senesco RNA Medicine Introduction
11.12.4 Senesco Revenue in RNA Medicine Business (2018-2023)
11.12.5 Senesco Recent Development
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Detail
11.13.2 Silence Therapeutics Business Overview
11.13.3 Silence Therapeutics RNA Medicine Introduction
11.13.4 Silence Therapeutics Revenue in RNA Medicine Business (2018-2023)
11.13.5 Silence Therapeutics Recent Development
11.14 Silenseed
11.14.1 Silenseed Company Detail
11.14.2 Silenseed Business Overview
11.14.3 Silenseed RNA Medicine Introduction
11.14.4 Silenseed Revenue in RNA Medicine Business (2018-2023)
11.14.5 Silenseed Recent Development
11.15 Tekmira
11.15.1 Tekmira Company Detail
11.15.2 Tekmira Business Overview
11.15.3 Tekmira RNA Medicine Introduction
11.15.4 Tekmira Revenue in RNA Medicine Business (2018-2023)
11.15.5 Tekmira Recent Development
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Detail
11.16.2 Alnylam Pharmaceuticals Business Overview
11.16.3 Alnylam Pharmaceuticals RNA Medicine Introduction
11.16.4 Alnylam Pharmaceuticals Revenue in RNA Medicine Business (2018-2023)
11.16.5 Alnylam Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNA Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of siRNA
Table 3. Key Players of ASO
Table 4. Key Players of miRNA
Table 5. Key Players of Nucleic Acid Aptamers
Table 6. Global RNA Medicine Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global RNA Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global RNA Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global RNA Medicine Market Share by Region (2018-2023)
Table 10. Global RNA Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global RNA Medicine Market Share by Region (2024-2034)
Table 12. RNA Medicine Market Trends
Table 13. RNA Medicine Market Drivers
Table 14. RNA Medicine Market Challenges
Table 15. RNA Medicine Market Restraints
Table 16. Global RNA Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global RNA Medicine Market Share by Players (2018-2023)
Table 18. Global Top RNA Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Medicine as of 2024)
Table 19. Ranking of Global Top RNA Medicine Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNA Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA Medicine Product Solution and Service
Table 23. Date of Enter into RNA Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global RNA Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global RNA Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global RNA Medicine Revenue Market Share by Type (2024-2034)
Table 29. Global RNA Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global RNA Medicine Revenue Market Share by Application (2018-2023)
Table 31. Global RNA Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global RNA Medicine Revenue Market Share by Application (2024-2034)
Table 33. North America RNA Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America RNA Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe RNA Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe RNA Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific RNA Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific RNA Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific RNA Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America RNA Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America RNA Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa RNA Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa RNA Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer RNA Medicine Product
Table 51. Pfizer Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche RNA Medicine Product
Table 56. Roche Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Sanofi-Aventis Company Detail
Table 59. Sanofi-Aventis Business Overview
Table 60. Sanofi-Aventis RNA Medicine Product
Table 61. Sanofi-Aventis Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 62. Sanofi-Aventis Recent Development
Table 63. Abbott Laboratories Company Detail
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories RNA Medicine Product
Table 66. Abbott Laboratories Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Arrowhead Pharmaceuticals Company Detail
Table 69. Arrowhead Pharmaceuticals Business Overview
Table 70. Arrowhead Pharmaceuticals RNA Medicine Product
Table 71. Arrowhead Pharmaceuticals Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 72. Arrowhead Pharmaceuticals Recent Development
Table 73. Benitec Biopharma Company Detail
Table 74. Benitec Biopharma Business Overview
Table 75. Benitec Biopharma RNA Medicine Product
Table 76. Benitec Biopharma Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 77. Benitec Biopharma Recent Development
Table 78. Calimmune Inc Company Detail
Table 79. Calimmune Inc Business Overview
Table 80. Calimmune Inc RNA Medicine Product
Table 81. Calimmune Inc Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 82. Calimmune Inc Recent Development
Table 83. Dicerna Company Detail
Table 84. Dicerna Business Overview
Table 85. Dicerna RNA Medicine Product
Table 86. Dicerna Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 87. Dicerna Recent Development
Table 88. Gradalis Company Detail
Table 89. Gradalis Business Overview
Table 90. Gradalis RNA Medicine Product
Table 91. Gradalis Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 92. Gradalis Recent Development
Table 93. Quark Company Detail
Table 94. Quark Business Overview
Table 95. Quark RNA Medicine Product
Table 96. Quark Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 97. Quark Recent Development
Table 98. RXi Company Detail
Table 99. RXi Business Overview
Table 100. RXi RNA Medicine Product
Table 101. RXi Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 102. RXi Recent Development
Table 103. Senesco Company Detail
Table 104. Senesco Business Overview
Table 105. Senesco RNA Medicine Product
Table 106. Senesco Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 107. Senesco Recent Development
Table 108. Silence Therapeutics Company Detail
Table 109. Silence Therapeutics Business Overview
Table 110. Silence Therapeutics RNA Medicine Product
Table 111. Silence Therapeutics Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 112. Silence Therapeutics Recent Development
Table 113. Silenseed Company Detail
Table 114. Silenseed Business Overview
Table 115. Silenseed RNA Medicine Product
Table 116. Silenseed Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 117. Silenseed Recent Development
Table 118. Tekmira Company Detail
Table 119. Tekmira Business Overview
Table 120. Tekmira RNA Medicine Product
Table 121. Tekmira Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 122. Tekmira Recent Development
Table 123. Alnylam Pharmaceuticals Company Detail
Table 124. Alnylam Pharmaceuticals Business Overview
Table 125. Alnylam Pharmaceuticals RNA Medicine Product
Table 126. Alnylam Pharmaceuticals Revenue in RNA Medicine Business (2018-2023) & (US$ Million)
Table 127. Alnylam Pharmaceuticals Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Medicine Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global RNA Medicine Market Share by Type: 2024 VS 2034
Figure 3. siRNA Features
Figure 4. ASO Features
Figure 5. miRNA Features
Figure 6. Nucleic Acid Aptamers Features
Figure 7. Global RNA Medicine Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global RNA Medicine Market Share by Application: 2024 VS 2034
Figure 9. Cancer Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Tuberculosis Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Others Case Studies
Figure 14. RNA Medicine Report Years Considered
Figure 15. Global RNA Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global RNA Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global RNA Medicine Market Share by Region: 2024 VS 2034
Figure 18. Global RNA Medicine Market Share by Players in 2024
Figure 19. Global Top RNA Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Medicine as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by RNA Medicine Revenue in 2024
Figure 21. North America RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America RNA Medicine Market Share by Country (2018-2034)
Figure 23. United States RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe RNA Medicine Market Share by Country (2018-2034)
Figure 27. Germany RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific RNA Medicine Market Share by Region (2018-2034)
Figure 35. China RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America RNA Medicine Market Share by Country (2018-2034)
Figure 43. Mexico RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa RNA Medicine Market Share by Country (2018-2034)
Figure 47. Turkey RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia RNA Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 51. Sanofi-Aventis Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 52. Abbott Laboratories Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 53. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 54. Benitec Biopharma Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 55. Calimmune Inc Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 56. Dicerna Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 57. Gradalis Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 58. Quark Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 59. RXi Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 60. Senesco Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 61. Silence Therapeutics Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 62. Silenseed Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 63. Tekmira Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 64. Alnylam Pharmaceuticals Revenue Growth Rate in RNA Medicine Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed